Literature DB >> 36128210

Mechanic's Hand Heralding Relapse in an Indian Adolescent with Anti-MDA5 Positive Juvenile Dermatomyositis.

Keya Ganatra1, Rohit Aggarwal2, Latika Gupta3.   

Abstract

Anti-MDA5 antibodies characterise a distinct phenotype of dermatomyositis in adults as well as children, with ethnic disparity in clinical presentation and severity. They often present as a diagnostic conundrum with rash, ulceration, and polyarthritis, but minimal muscle disease. Mechanic's hands are typically associated with anti-synthetase syndrome, but their presence in anti-MDA5 antibody positive patients, although reported, is not well known. We present the case of a boy in whom mechanic's hand heralded a relapse of juvenile dermatomyositis which was suspected based on remotely assessed patient-reported outcome measures on teleconsultation. This report suggests that mechanic's hands should also prompt testing for myositis antibodies including anti-MDA5 in Indian children with JDM. Diligent awareness of the condition, and timely use of patient reported outcome measures of muscle power and skin assessment may guide management while delivering remote care in challenging situations such as a global pandemic.
© 2022 The Mediterranean Journal of Rheumatology (MJR).

Entities:  

Keywords:  anti-MDA5 antibodies; autoimmune myositis; juvenile dermatomyositis

Year:  2022        PMID: 36128210      PMCID: PMC9450195          DOI: 10.31138/mjr.33.2.268

Source DB:  PubMed          Journal:  Mediterr J Rheumatol        ISSN: 2529-198X


Dear Editor, An 18-year-old boy diagnosed with juvenile dermatomyositis (JDM) three years ago in remission on Methotrexate presented with erythematous rashes after disrupted medication supply due to logistic challenges during the COVID-19 pandemic. A relapse was suspected on Teleconsultation with a two-minute walk distance of 147.9 metres (normal >180 metres) and ten times arm lift time of 12.02 seconds (normal ∼10–12 seconds). Physical examination confirmed relapse, with initial development of mechanic’s hands, followed a week later by a periorbital Heliotrope rash, Gottron’s papules, patchy alopecia, and hyperpigmentation of ear lobes in areas of previous healed rashes (figure 1A–F). Manual muscle testing 8 score was 61 (maximum of 80) and muscle enzymes elevated (CK 213 U/I, LDH 1013 U/I, AST 140 U/I, ALT 81 U/I). The patient had no dyspnea, shortness of breath or other respiratory symptoms. On initial presentation 3 years ago, he was diagnosed with anti-Melanoma Differentiation Associated protein (MDA5) antibodies associated JDM when he presented with classic JDM rashes, muscle weakness, and bilateral basal ground glass opacities on contrast enhanced CT of chest suggestive of interstitial lung disease (ILD). However, the patient had no rash indicative of mechanic’s hands at the time of initial presentation.
Figures:

(A) Heliotrope Rash and lip oedema (B) Gottron’s papules (C, D) Mechanic’s hand (E) Patchy alopecia (F) Hyperpigmentation of ear lobes.

(A) Heliotrope Rash and lip oedema (B) Gottron’s papules (C, D) Mechanic’s hand (E) Patchy alopecia (F) Hyperpigmentation of ear lobes. Anti-MDA5 antibodies characterise a distinct phenotype in adults as well as children, with ethnic disparity in clinical presentation and severity.[1] They often present as a diagnostic conundrum with rash, ulceration, and polyarthritis but minimal muscle disease. Severe forms of ILD are reportedly limited to the Japanese population. This case suggests that a similar phenotype may be manifest in Indian adolescents with JDM in association with chronic ILD.[3] Mechanic’s hands are typically associated with anti-synthetase syndrome but its presence in anti-MDA5 antibody positive patients, although reported, is not well known.[2,3] Thus, mechanic’s hand should also prompt testing for myositis antibodies including anti-MDA5 in Indian children with JDM. Diligent awareness of the condition, and timely use of remote measures of muscle power and skin assessment may guide management while delivering remote care in challenging situations, such as a global pandemic.[4] The presence of Mechanic’s hands in anti-MDA5 antibody positive patients, although reported, is not well known. This report suggests that mechanic’s hands should also prompt testing for myositis antibodies including anti-MDA5 in Indian children with JDM.
  4 in total

1.  Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.

Authors:  Latika Gupta; R Naveen; Priyanka Gaur; Vikas Agarwal; Rohit Aggarwal
Journal:  Semin Arthritis Rheum       Date:  2020-12-22       Impact factor: 5.532

2.  Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.

Authors:  Sarah L Tansley; Zoe E Betteridge; Harsha Gunawardena; Thomas S Jacques; Catherine M Owens; Clarissa Pilkington; Katie Arnold; Shireena Yasin; Elena Moraitis; Lucy R Wedderburn; Neil J McHugh
Journal:  Arthritis Res Ther       Date:  2014-07-02       Impact factor: 5.156

3.  Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.

Authors:  Yves Allenbach; Yurdagul Uzunhan; Ségolène Toquet; Gaëlle Leroux; Laure Gallay; Alicia Marquet; Alain Meyer; Constance Guillaud; Nicolas Limal; Frédéric Gagnadoux; Baptiste Hervier; Raphaël Borie; Christophe Deligny; Benjamin Terrier; Alice Berezne; Sylvain Audia; Nicolas Champtiaux; Hervé Devilliers; Nicol Voermans; Elizabeth Diot; Amélie Servettaz; Thierry Marhadour; Vincent Castelain; Sébastien Humbert; Claire Blanchard-Delaunay; Nathalie Tieulie; Pierre Charles; Magdalena Gerin; Arsène Mekinian; Pascaline Priou; Jean Claude Meurice; Abdellatif Tazi; Vincent Cottin; Makoto Miyara; Benjamin Grange; Dominique Israël-Biet; Sophie Phin-Huynh; Camille Bron; Luc De Saint Martin; Nicole Fabien; Kubéraka Mariampillai; Hilario Nunes; Olivier Benveniste
Journal:  Neurology       Date:  2020-06-02       Impact factor: 9.910

4.  COVID-19 and myositis - unique challenges for patients.

Authors:  Latika Gupta; James B Lilleker; Vikas Agarwal; Hector Chinoy; Rohit Aggarwal
Journal:  Rheumatology (Oxford)       Date:  2020-11-11       Impact factor: 7.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.